Akèy › Kansè tete negatif triple › New York › Greenburgh
Etid klinik pou Kansè tete negatif triple nan Greenburgh, NY
7 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Greenburgh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi lwen
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Ap rekriteFaz 3
- White Plains Hospital Physician Associates, White Plains · 4 mi lwen
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Ap rekriteFaz 2/3
- White Plains Hospital, White Plains · 4 mi lwen
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
Etid Kansè tete negatif triple nan lòt vil
- Houston, TX42 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Los Angeles, CA27 etid
- Boston, MA26 etid
- San Antonio, TX23 etid
- St. Louis, MO21 etid
- Arlington, VA20 etid
- Atlanta, GA20 etid
- Dallas, TX18 etid
- Chicago, IL16 etid
- Columbus, OH16 etid
Lòt etid nan Greenburgh
- Kansè nan tete42 etid
- Kansè Poumon ki pa ti selil28 etid
- Leksemi mieloïd egi18 etid
- Kansè pwostat17 etid
- Kansè (tout kalite)17 etid
- Kansè poumon17 etid
- Myelom Miltip13 etid
- Kansè kolorektal11 etid
- Kansè Metastatik11 etid
- Kansè Endomèt11 etid
- Kansè vejik10 etid
- Limfom9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.